Dimethyl fumarate suppresses Tc17 cell fate in autoimmunity via ROS accumulation

Lückel, Christina

Dimethyl fumarate suppresses Tc17 cell fate in autoimmunity via ROS accumulation

Dimethyl fumarate (DMF) is approved for treatment of relapsing remitting multiple sclerosis (RRMS), a chronic inflammatory disease of the central nervous system (CNS) that is caused by autoreactive T cells. The effect mechanism of DMF is not fully elucidated so far; however, a preferential impact on...

Ful tanımlama

Kaydedildi:

Detaylı Bibliyografya
Yazar:	Lückel, Christina
Diğer Yazarlar:	Huber, Magdalena (Prof. Dr.) (Tez danışmanı)
Materyal Türü:	Dissertation
Dil:	İngilizce
Baskı/Yayın Bilgisi:	Philipps-Universität Marburg 2018
Konular:	multiple sclerosis IL-17 Multiple Sklerose ROS Tc17 cells Dimethyl fumarate Tc17 Zellen Dimethylfumarat Medizin Medical sciences Medicine
Online Erişim:	PDF Tam Metin
Etiketler:	Etiketle Etiket eklenmemiş, İlk siz ekleyin!

İlk yorumlayan siz olun!

Dimethyl fumarate suppresses Tc17 cell fate in autoimmunity via ROS accumulation

Benzer Materyaller